Arylthioindoles, potent inhibitors of tubulin polymerization

被引:277
作者
De Martino, G
La Regina, G
Coluccia, A
Edler, MC
Barbera, MC
Brancale, A
Wilcox, E
Hamel, E
Artico, M
Silvestri, R
机构
[1] Univ Roma La Sapienza, Dipartimento Studi Farmaceut, I-00185 Rome, Italy
[2] Cardiff Univ, Welsh Sch Pharm, Cardiff CF10 3XF, S Glam, Wales
[3] NCI, Screening Technol Branch, Dev Therapeut Program, Div Canc Treatment & Diag,NIH, Frederick, MD 21702 USA
关键词
D O I
10.1021/jm049360d
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Several arylthioindoles had excellent activity as inhibitors both of tubulin polymerization and of the growth of MCF-7 human breast carcinoma cells. Methyl 3-[(3,4,5-trimethoxyphenyl)thio]-5-methoxy-1H-indole-2-carboxylate (21), the most potent derivative, showed IC50 = 2.0 muM, 1.6 times more active than colchicine and about as active as combretastatin A-4 (CSA4). Compound 21 inhibited the growth of the MCF-7 cells at IC50 = 13 nM. Colchicine and CSA4 had 13 nM and 17 nM IC50 values, respectively, with these cells.
引用
收藏
页码:6120 / 6123
页数:4
相关论文
共 19 条
[11]   ANTIMITOTIC NATURAL-PRODUCTS COMBRETASTATIN-A-4 AND COMBRETASTATIN-A-2 - STUDIES ON THE MECHANISM OF THEIR INHIBITION OF THE BINDING OF COLCHICINE TO TUBULIN [J].
LIN, CM ;
HO, HH ;
PETTIT, GR ;
HAMEL, E .
BIOCHEMISTRY, 1989, 28 (17) :6984-6991
[12]   Synthesis and antineoplastic activity of combretastatin analogues:: Heterocombretastatins [J].
Medarde, M ;
Ramos, A ;
Caballero, E ;
de Clairac, RPL ;
López, JL ;
Grávalos, DG ;
San Feliciano, A .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 1998, 33 (01) :71-77
[13]  
Pohle K, 1965, Arch Geschwulstforsch, V25, P17
[14]  
Prinz Helge, 2002, Expert Rev Anticancer Ther, V2, P695, DOI 10.1586/14737140.2.6.695
[15]   Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain [J].
Ravelli, RBG ;
Gigant, B ;
Curmi, PA ;
Jourdain, I ;
Lachkar, S ;
Sobel, A ;
Knossow, M .
NATURE, 2004, 428 (6979) :198-202
[16]   PROMOTION OF MICROTUBULE ASSEMBLY INVITRO BY TAXOL [J].
SCHIFF, PB ;
FANT, J ;
HORWITZ, SB .
NATURE, 1979, 277 (5698) :665-667
[17]   Novel indolyl aryl sulfones active against HIV-1 carrying NNRTI resistance mutations: Synthesis and SAR studies [J].
Silvestri, R ;
De Martino, G ;
La Regina, G ;
Artico, M ;
Massa, S ;
Vargiu, L ;
Mura, M ;
Loi, AG ;
Marceddu, T ;
La Colla, P .
JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (12) :2482-2493
[18]   Structure-activity analysis of the interaction of curacin A, the potent colchicine site antimitotic agent, with tubulin and effects of analogs on the growth of MCF-7 breast cancer cells [J].
Verdier-Pinard, P ;
Lai, JY ;
Yoo, HD ;
Yu, JR ;
Marquez, B ;
Nagle, DG ;
Nambu, M ;
White, JD ;
Falck, JR ;
Gerwick, WH ;
Day, BW ;
Hamel, E .
MOLECULAR PHARMACOLOGY, 1998, 53 (01) :62-76
[19]   Phase I study of E7010 [J].
Yamamoto, K ;
Noda, K ;
Yoshimura, A ;
Fukuoka, M ;
Furuse, K ;
Niitani, H .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1998, 42 (02) :127-134